Search bioRxiv⌕ Search

Biology subjects

Ahrensback Roesgaard, M.

Publications and source records attributed to Ahrensback Roesgaard, M..

2 recordsLinked to original sources

Mitochondrial Lon protease couples substrate translocation to proteolytic activation

Human LonP1 is an ATP-dependent mitochondrial protease that degrades damaged or redundant proteins. Indiscriminate proteolysis by LonP1 is limited through tight coordination of substrate recognition, unfolding, translocation and catalytic cleavage, yet the role of ATP hydrolysis in these individual steps remains unclear. Here, we show that LonP1 binds substrates and cleaves peptide bonds without ATP hydrolysis, whereas degradation of folded proteins strictly depends on ATP-driven unfolding and translocation. Initial substrate binding opens a closed ADP-bound resting state, enabling nucleotide exchange and stimulating ATPase activity. The opening also increases accessibility of the proteolytic chamber, modestly enhancing peptidase activity. Maximal peptidase activity is observed in a transition-state mimic stabilised by ADP{middle dot}AlF, in which substrate is engaged within the translocation channel. Cryo-EM analysis reveals that in this state the proteolytic active sites are no longer occluded, linking ATP-driven substrate translocation to full proteolytic activation. Together, these findings reveal how LonP1 prevents indiscriminate proteolysis during substrate selection by ensuring that efficient proteolysis occurs only in substrate-translocating states. Model of the conformational landscape and functional cycle of LonP1Schematic overview of LonP1 states and their inter-conversion. State transitions are modulated by substrate, nucleotide occupancy, temperature, and inhibitors. Key distinguishing features include the presence or absence of the lateral gap, nucleotide state, substrate engagement within the A-tunnel, and the handedness of the ATPase (A) domains. Additional indicators include the compactness of the proteolytic (P) domain and the presence of substrate density within the N-terminal (N) domain or at the coiled-coil domain (CCD) as well as the position of a loop within the catalytic centre. The depicted cryo-EM structures represent a model of a continuous conformational landscape and correspond to the closest matching biological states and positions within the reaction cycle, but may also capture transient intermediates or conformations stabilised by experimental conditions. The shown atomic models correspond to the states highlighted in larger font (R-state: PDB 7NGL; P1-state: PDB 7NFY; P2-state: PDB 7NGC; closed LonP1-ADP-substrate: PDB 9CC1). O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=118 SRC="FIGDIR/small/733973v1_ufig1.gif" ALT="Figure 1"> View larger version (59K): org.highwire.dtl.DTLVardef@62128forg.highwire.dtl.DTLVardef@b0a5faorg.highwire.dtl.DTLVardef@160ea7forg.highwire.dtl.DTLVardef@1c35e82_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗

LonP1 chaperone-like activity is ATPase independent and is mediated by its N-domain

The mitochondrial Lon protease is essential for proteostasis through ATP-dependent proteolysis and suppression of protein aggregation through an unknown mechanism. Here we show in three independent aggregation systems that human Lon protease (LonP1) directly interacts with fibrillar aggregates to prevent further aggregation: LonP1 binds amyloid fibrils and inhibits their growth, independently of its protease and ATPase activities. This aggregation inhibition depends on hexamer stability, and even the N-domain hexamer of LonP1 lacking all catalytic domains inhibited aggregation, which localizes its fibril-binding interface. We propose that chaperone deficiencies in LonP1 mutants that are associated with genetic disease, are caused by reduced hexamer stability or increased turnover. Our results clarify the observed dual protease and chaperone function of LonP1 by localizing them to different domains and separating the catalytic activities, thereby facilitating targeting the specific functionalities. Further, we identify the structure of the chaperone substrate to be fibrillar aggregates, suggesting that LonP1 may protect against amyloid fibrils in healthy individuals. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=176 SRC="FIGDIR/small/723147v3_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@1715a1eorg.highwire.dtl.DTLVardef@d382fborg.highwire.dtl.DTLVardef@3c3fa0org.highwire.dtl.DTLVardef@1753f3e_HPS_FORMAT_FIGEXP M_FIG C_FIG SignificanceThe mitochondrial Lon protease has long been proposed to function both as a protease and as a chaperone, though the mechanism of its chaperone activity is debated. Here, we show that human Lon binds to fibrillar protein aggregates and inhibits their elongation, but do not find evidence for chaperoning unfolded chains. Further, our findings challenge the current view that ATPase activity is required for Lon chaperone function. Instead, our results suggest that chaperone deficiency of Lon variants can be explained by variant stability. Our results provide a mechanistic separation of the protease and chaperone-like function LonP1, thereby opening up for targeting one of the functions specifically, and provide new insight into how Lon dysfunction may contribute in multiple ways to age-related and proteostasis-related diseases.

biochemistry↗